EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches

Amit Sharma, Dario Sangiolo, Antonio Rosato, Jingjing Pu, Jian Hou, Sarah Tettamanti, Marta Serafini, Kevin Aaron Fenix, Martino Introna, Alessandro Rambaldi, Xiubao Ren, Ingo G H Schmidt-Wolf

Cancer Immunology, Immunotherapy · 2025

DOI: 10.1007/s00262-025-04216-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Amit Sharma und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Oncology, Center for Integrated Oncology (CIO) Bonn, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Cytokine-Induced Killer Cells, Immunotherapy, Adoptive, Dendritic Cells, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

On April 7, 2025, the 2nd International CIK Cell Conference was held in Monza, Italy, marking the establishment of the International Society for CIK Cells (ISCC). The conference, kindly supported by Fondazione Tettamanti (Italy), featured cutting-edge advancements in cytokine-induced killer (CIK) cell immunotherapy, used alone and in combination with dendritic cells (DC-CIK) and chimeric antigen receptors (CAR-CIK). The event also provided a valuable opportunity for young investigators to engage in insightful discussions and to network within experts in the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytokine-Induced Killer CellsImmunotherapy, AdoptiveDendritic CellsReceptors, Chimeric AntigenNeoplasmsImmunotherapyHumans

Stichwörter der Autor:innen

CAR-CIKCytokine-induced killer (CIK) cell immunotherapyDC-CIKISCCInternational society for CIK cells

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Integrated Oncology, Center for Integrated Oncology (CIO) Bonn, University Hospital Bonn, Bonn, Germany.
  • Department of Oncology, University of Turin, Turin, Italy.
  • Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.
  • Department of Hematology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
  • Tettamanti Center, Fondazione IRCCS San Gerardo Dei Tintori, Monza, Italy.
  • Discipline of Surgery, Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.

Zitieren

APA

Sharma, A., Sangiolo, D., Rosato, A., Pu, J., Hou, J., Tettamanti, S., Serafini, M., Fenix, K. A., Introna, M., Rambaldi, A., Ren, X., & Schmidt-Wolf, I. G. H. (2025). Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-025-04216-8

Vancouver

Sharma A, Sangiolo D, Rosato A, Pu J, Hou J, Tettamanti S, et al. Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-025-04216-8

BibTeX
@article{Sharma2025,
  author = {Sharma, Amit and Sangiolo, Dario and Rosato, Antonio and Pu, Jingjing and Hou, Jian and Tettamanti, Sarah and Serafini, Marta and Fenix, Kevin Aaron and Introna, Martino and Rambaldi, Alessandro and Ren, Xiubao and Schmidt-Wolf, Ingo G H},
  title = {Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2025},
  doi = {10.1007/s00262-025-04216-8}
}
Kostenlos starten →